MISSISSAUGA, ONTARIO -- (MARKET WIRE) -- May 23, 2007 -- BioSyent Inc. (“BioSyent”, the “Company”)(TSX VENTURE: RX) today released its first quarter 2007 financial results. Sales for the quarter ended March 31, 2007 were $302,840, an increase of 17% versus $258,763 in the same period in 2006. The increase in sales was mainly due to an increase in Canadian orders for Protect-It®. FeraMAX™ shipments to wholesale customers commenced in April 2007 and as a result the first quarter sales result do not include any sales of that product. The first quarter sales increase coupled with a 0.5% improvement in product margin, increased gross profit by 18%, from $159,601 in the 2006 first quarter to $188,247 in the 2007 first quarter.
